수의용 주사제 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 동물별, 치료 분야별, 제형별, 투여 경로별, 약물 유형별, 유통 채널별, 지역별 및 부문별 예측(2026-2033년)

Veterinary Injectables Market Summary

The global veterinary injectables market size was valued at USD 23.7 billion in 2025 and is projected to grow from USD 25.6 billion in 2026 to USD 46.5 billion by 2033, at 8.9% CAGR from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 35.2% in 2025. The market growth is driven by increasing demand for injectable antibiotics, vaccines, analgesics, anti-inflammatory drugs, anesthetics, and other therapeutic products across companion and production animals.

Rising prevalence of parasiticides, increasing livestock production, and greater adoption of preventive veterinary care support the demand for injectable treatments in the veterinary injectables industry. Moreover, technological advancements in long-acting formulations, injectable biologics, drug delivery systems, formulation development, and sterile manufacturing are improving treatment duration, dosing efficiency, product stability, and manufacturing scalability.

Global Veterinary Injectables Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary injectables market report based on product, animal, therapeutic area, dosage form, route of administration, drug type, distribution channel, and region:

• Product Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Small Molecules/Conventional Drugs
• Biologics
• Biosimilars
• Animal Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Production Animals
  • Poultry
  • Swine
  • Bovine
  • Ovine & Caprine
  • Others
• Companion Animals
  • Canine
  • Feline
  • Equine
  • Others
• Therapeutic Area (Revenue, USD Million/Billion, 2021 - 2033)
• Parasiticides
• Anti-infectives
• Analgesics & Anti-inflammatory
• Hormonal & Reproductive Drugs
• Nutritional Injectables
• Others
• Dosage Form Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Solution
• Suspension
• Powder for Reconstitution/Lyophilized Powder
• Others
• Route of Administration (Revenue, USD Million/Billion, 2021 - 2033)
• Subcutaneous
• Intravenous
• Intramuscular
• Others
• Drug Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Branded
• Generic
• Distribution Channel Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Veterinary Hospitals & Clinics
• E-commerce
• Offline Retail Stores
• Others
• Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Norway
  • Denmark
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Oman
  • Qatar

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Animal
  • 1.2.3. Therapeutic Area
  • 1.2.4. Dosage Form
  • 1.2.5. Route of Administration
  • 1.2.6. Drug Type
  • 1.2.7. Distribution Channel
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Top-Down Analysis
  • 1.7.3. Botton-up Approach
  • 1.7.4. Multivariate Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Demand for Injectable Therapeutics
    • 3.2.1.2. Rising Livestock Production and Preventive Healthcare Adoption
    • 3.2.1.3. Advancements in Injectable Formulations and Drug Delivery
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Administration Costs and Requirement for Skilled Veterinary Personnel
    • 3.2.2.2. Risk of Injection-Site Reactions and Treatment-Related Complications
• 3.3. Market Opportunities
• 3.4. Market Challenges
• 3.5. Technology Landscape
• 3.6. Estimated Animal Population, by Key Countries, by Key Species, 2025
• 3.7. Market Analysis Tools
  • 3.7.1. Porter's Five Forces Analysis
  • 3.7.2. PESTEL Analysis

Chapter 4. Veterinary Injectables Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Veterinary Injectables Market: Product Movement Analysis
• 4.3. Veterinary Injectables Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million/Billion)
• 4.4. Small Molecules/Conventional Drugs
  • 4.4.1. Small Molecules/Conventional Drugs Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
• 4.5. Biologics
  • 4.5.1. Biologics Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
• 4.6. Biosimilars
  • 4.6.1. Biosimilars Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)

Chapter 5. Veterinary Injectables Market: Animal Estimates & Trend Analysis

• 5.1. Animal Segment Dashboard
• 5.2. Veterinary Injectables Market: Animal Movement Analysis
• 5.3. Veterinary Injectables Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million/Billion)
• 5.4. Production Animals
  • 5.4.1. Production Animals Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
  • 5.4.2. Poultry
    • 5.4.2.1. Poultry Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
  • 5.4.3. Swine
    • 5.4.3.1. Swine Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
  • 5.4.4. Bovine
    • 5.4.4.1. Bovine Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
  • 5.4.5. Ovine & Caprine
    • 5.4.5.1. Ovine & Caprine Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
  • 5.4.6. Others
    • 5.4.6.1. Others Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
• 5.5. Companion Animals
  • 5.5.1. Companion Animals Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
  • 5.5.2. Canine
    • 5.5.2.1. Canine Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
  • 5.5.3. Feline
    • 5.5.3.1. Feline Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
  • 5.5.4. Equine
    • 5.5.4.1. Equine Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
  • 5.5.5. Others
    • 5.5.5.1. Others Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)

Chapter 6. Veterinary Injectables Market: Therapeutic Area Estimates & Trend Analysis

• 6.1. Therapeutic Area Segment Dashboard
• 6.2. Veterinary Injectables Market: Therapeutic Area Movement Analysis
• 6.3. Veterinary Injectables Market Estimates & Forecasts, by Therapeutic Area, 2021 to 2033 (USD Million/Billion)
• 6.4. Parasiticides
  • 6.4.1. Parasiticides Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 6.5. Anti-infectives
  • 6.5.1. Anti-infectives Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 6.6. Analgesics & Anti-inflammatory
  • 6.6.1. Analgesics & Anti-inflammatory Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 6.7. Hormonal & Reproductive Drugs
  • 6.7.1. Hormonal & Reproductive Drugs Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 6.8. Nutritional Injectables
  • 6.8.1. Nutritional Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 6.9. Others
  • 6.9.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 7. Veterinary Injectables Market: Dosage Form Estimates & Trend Analysis

• 7.1. Dosage Form Segment Dashboard
• 7.2. Veterinary Injectables Market: Dosage Form Movement Analysis
• 7.3. Veterinary Injectables Market Estimates & Forecasts, by Dosage Form, 2021 to 2033 (USD Million/Billion)
• 7.4. Solution
  • 7.4.1. Solution Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 7.5. Suspension
  • 7.5.1. Suspension Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 7.6. Powder for Reconstitution/Lyophilized Powder
  • 7.6.1. Powder for Reconstitution/Lyophilized Powder Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 7.7. Others
  • 7.7.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 8. Veterinary Injectables Market: Route of Administration Estimates & Trend Analysis

• 8.1. Route of Administration Platform Segment Dashboard
• 8.2. Veterinary Injectables Market: Route of Administration Movement Analysis
• 8.3. Veterinary Injectables Market Estimates & Forecasts, by Route of Administration, 2021 to 2033 (USD Million/Billion)
• 8.4. Subcutaneous
  • 8.4.1. Subcutaneous Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 8.5. Intravenous
  • 8.5.1. Intravenous Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 8.6. Intramuscular
  • 8.6.1. Intramuscular Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 8.7. Others
  • 8.7.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 9. Veterinary Injectables Market: Drug Type Estimates & Trend Analysis

• 9.1. Drug Type Segment Dashboard
• 9.2. Veterinary Injectables Market: Drug Type Movement Analysis
• 9.3. Veterinary Injectables Market Estimates & Forecasts, by Drug Type, 2021 to 2033 (USD Million/Billion)
• 9.4. Branded
  • 9.4.1. Branded Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 9.5. Generic
  • 9.5.1. Generic Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 10. Veterinary Injectables Market: Distribution Channel Estimates & Trend Analysis

• 10.1. Distribution Channel Segment Dashboard
• 10.2. Veterinary Injectables Market: Distribution Channel Movement Analysis
• 10.3. Veterinary Injectables Market Estimates & Forecasts, by Distribution Channel, 2021 to 2033 (USD Million/Billion)
• 10.4. Veterinary Hospitals & Clinics
  • 10.4.1. Veterinary Hospitals & Clinics Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 10.5. E-commerce
  • 10.5.1. E-commerce Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 10.6. Offline Retail Stores
  • 10.6.1. Offline Retail Stores Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 10.7. Others
  • 10.7.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 11. Veterinary Injectables Market: Regional Estimates & Trend Analysis

• 11.1. Regional Market Dashboard
• 11.2. Veterinary Injectables Market: Regional Movement Analysis
• 11.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
• 11.4. North America
  • 11.4.1. North America Veterinary Injectables Market Estimates & Forecasts, By Country, 2021 - 2033 (USD Million/Billion)
  • 11.4.2. U.S.
    • 11.4.2.1. Key Country Dynamics
    • 11.4.2.2. Competitive Scenario
    • 11.4.2.3. Regulatory Framework
    • 11.4.2.4. U.S. Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.4.3. Canada
    • 11.4.3.1. Key Country Dynamics
    • 11.4.3.2. Competitive Scenario
    • 11.4.3.3. Regulatory Framework
    • 11.4.3.4. Canada Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.4.4. Mexico
    • 11.4.4.1. Key Country Dynamics
    • 11.4.4.2. Competitive Scenario
    • 11.4.4.3. Regulatory Framework
    • 11.4.4.4. Mexico Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 11.5. Europe
  • 11.5.1. Europe Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.5.2. UK
    • 11.5.2.1. Key Country Dynamics
    • 11.5.2.2. Competitive Scenario
    • 11.5.2.3. Regulatory Framework
    • 11.5.2.4. UK Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.5.3. Germany
    • 11.5.3.1. Key Country Dynamics
    • 11.5.3.2. Competitive Scenario
    • 11.5.3.3. Regulatory Framework
    • 11.5.3.4. Germany Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.5.4. France
    • 11.5.4.1. Key Country Dynamics
    • 11.5.4.2. Competitive Scenario
    • 11.5.4.3. Regulatory Framework
    • 11.5.4.4. France Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.5.5. Italy
    • 11.5.5.1. Key Country Dynamics
    • 11.5.5.2. Competitive Scenario
    • 11.5.5.3. Regulatory Framework
    • 11.5.5.4. Italy Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.5.6. Spain
    • 11.5.6.1. Key Country Dynamics
    • 11.5.6.2. Competitive Scenario
    • 11.5.6.3. Regulatory Framework
    • 11.5.6.4. Spain Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.5.7. Denmark
    • 11.5.7.1. Key Country Dynamics
    • 11.5.7.2. Competitive Scenario
    • 11.5.7.3. Regulatory Framework
    • 11.5.7.4. Denmark Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.5.8. Sweden
    • 11.5.8.1. Key Country Dynamics
    • 11.5.8.2. Competitive Scenario
    • 11.5.8.3. Regulatory Framework
    • 11.5.8.4. Sweden Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.5.9. Norway
    • 11.5.9.1. Key Country Dynamics
    • 11.5.9.2. Competitive Scenario
    • 11.5.9.3. Regulatory Framework
    • 11.5.9.4. Norway Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 11.6. Asia Pacific
  • 11.6.1. Asia Pacific Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.6.2. Japan
    • 11.6.2.1. Key Country Dynamics
    • 11.6.2.2. Competitive Scenario
    • 11.6.2.3. Regulatory Framework
    • 11.6.2.4. Japan Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.6.3. China
    • 11.6.3.1. Key Country Dynamics
    • 11.6.3.2. Competitive Scenario
    • 11.6.3.3. Regulatory Framework
    • 11.6.3.4. China Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.6.4. India
    • 11.6.4.1. Key Country Dynamics
    • 11.6.4.2. Competitive Scenario
    • 11.6.4.3. Regulatory Framework
    • 11.6.4.4. India Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.6.5. Australia
    • 11.6.5.1. Key Country Dynamics
    • 11.6.5.2. Competitive Scenario
    • 11.6.5.3. Regulatory Framework
    • 11.6.5.4. Australia Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.6.6. South Korea
    • 11.6.6.1. Key Country Dynamics
    • 11.6.6.2. Competitive Scenario
    • 11.6.6.3. Regulatory Framework
    • 11.6.6.4. South Korea Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.6.7. Thailand
    • 11.6.7.1. Key Country Dynamics
    • 11.6.7.2. Competitive Scenario
    • 11.6.7.3. Regulatory Framework
    • 11.6.7.4. Thailand Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 11.7. Latin America
  • 11.7.1. Latin America Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.7.2. Brazil
    • 11.7.2.1. Key Country Dynamics
    • 11.7.2.2. Competitive Scenario
    • 11.7.2.3. Regulatory Framework
    • 11.7.2.4. Brazil Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.7.3. Argentina
    • 11.7.3.1. Key Country Dynamics
    • 11.7.3.2. Competitive Scenario
    • 11.7.3.3. Regulatory Framework
    • 11.7.3.4. Argentina Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
• 11.8. Middle East and Africa
  • 11.8.1. Middle East and Africa Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.8.2. South Africa
    • 11.8.2.1. Key Country Dynamics
    • 11.8.2.2. Competitive Scenario
    • 11.8.2.3. Regulatory Framework
    • 11.8.2.4. South Africa Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.8.3. Saudi Arabia
    • 11.8.3.1. Key Country Dynamics
    • 11.8.3.2. Competitive Scenario
    • 11.8.3.3. Regulatory Framework
    • 11.8.3.4. Saudi Arabia Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.8.4. UAE
    • 11.8.4.1. Key Country Dynamics
    • 11.8.4.2. Competitive Scenario
    • 11.8.4.3. Regulatory Framework
    • 11.8.4.4. UAE Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.8.5. Kuwait
    • 11.8.5.1. Key Country Dynamics
    • 11.8.5.2. Competitive Scenario
    • 11.8.5.3. Regulatory Framework
    • 11.8.5.4. Kuwait Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.8.6. Oman
    • 11.8.6.1. Key Country Dynamics
    • 11.8.6.2. Competitive Scenario
    • 11.8.6.3. Regulatory Framework
    • 11.8.6.4. Oman Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
  • 11.8.7. Qatar
    • 11.8.7.1. Key Country Dynamics
    • 11.8.7.2. Competitive Scenario
    • 11.8.7.3. Regulatory Framework
    • 11.8.7.4. Qatar Veterinary Injectables Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 12. Competitive Landscape

• 12.1. Key Participant Categorization
  • 12.1.1. Market Leaders
  • 12.1.2. Emerging Players
• 12.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
• 12.3. Company Profiles/Listing
  • 12.3.1. Zoetis Services LLC
    • 12.3.1.1. Company overview
    • 12.3.1.2. Financial performance
    • 12.3.1.3. Product benchmarking
    • 12.3.1.4. Strategic initiatives
  • 12.3.2. Merck & Co., Inc.
    • 12.3.2.1. Company overview
    • 12.3.2.2. Financial performance
    • 12.3.2.3. Product benchmarking
    • 12.3.2.4. Strategic initiatives
  • 12.3.3. Boehringer Ingelheim International GmbH
    • 12.3.3.1. Company overview
    • 12.3.3.2. Financial performance
    • 12.3.3.3. Product benchmarking
    • 12.3.3.4. Strategic initiatives
  • 12.3.4. Elanco
    • 12.3.4.1. Company overview
    • 12.3.4.2. Financial performance
    • 12.3.4.3. Product benchmarking
    • 12.3.4.4. Strategic initiatives
  • 12.3.5. Ceva
    • 12.3.5.1. Company overview
    • 12.3.5.2. Financial performance
    • 12.3.5.3. Product benchmarking
    • 12.3.5.4. Strategic initiatives
  • 12.3.6. Virbac
    • 12.3.6.1. Company overview
    • 12.3.6.2. Financial performance
    • 12.3.6.3. Product benchmarking
    • 12.3.6.4. Strategic initiatives
  • 12.3.7. Vetoquinol
    • 12.3.7.1. Company overview
    • 12.3.7.2. Financial performance
    • 12.3.7.3. Product benchmarking
    • 12.3.7.4. Strategic initiatives
  • 12.3.8. Dechra
    • 12.3.8.1. Company overview
    • 12.3.8.2. Financial performance
    • 12.3.8.3. Product benchmarking
    • 12.3.8.4. Strategic initiatives
  • 12.3.9. Phibro Animal Health
    • 12.3.9.1. Company overview
    • 12.3.9.2. Financial performance
    • 12.3.9.3. Product benchmarking
    • 12.3.9.4. Strategic initiatives
  • 12.3.10. Bimeda Corporate
    • 12.3.10.1. Company overview
    • 12.3.10.2. Financial performance
    • 12.3.10.3. Product benchmarking
    • 12.3.10.4. Strategic initiatives